accounthas been a strength of Pfizer's, although we can argue whether it overpaid for Warner-Lambert, Pharmacia, and Wyeth. The big unknown is how much cash and debt will be shed in the spin offs and how much will be retained. Pfizer currently has a war chest...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to How to Play the Pfizer Breakup (If It Happens)
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account